¸£ÖÝÖпư×ñ°·çÑо¿Ëù > ¿ÆÑж¯Ì¬ >

ÔÚÏß×Éѯ

ÈÕÆÚ£º2014-04-30 À´Ô´£º ¸£ÖÝÖпư×ñ°·çÑо¿Ëù ÊղشËÎÄÕµ½£ºÊղؼÐ-°Ù¶ÈËѲØ

[ÕªÒª] °×ñ°·çÊÇÒ»ÖÖÉ«ËØÍÑʧÐÔ¼²²¡¡£¶ø¹âÁÆ×÷ΪÆäÖ÷ÒªÖÎÁÆ·½·¨Ö®Ò»±»¹ã·ºÔËÓᣱ¾ÎľͰüÀ¨¹â»¯Ñ§ÁÆ·¨£¬Õ­Æ×Öв¨×ÏÍâÏߣ¬308ª²nm×¼·Ö×ӵȹâÁÆ·¨½üÄêÀ´µÄ·¢Õ¹×÷Ò»×ÛÊö¡£......

¡¡¡¡¡¾ÕªÒª¡¿  °×ñ°·çÊÇÒ»ÖÖÉ«ËØÍÑʧÐÔ¼²²¡¡£¶ø¹âÁÆ×÷ΪÆäÖ÷ÒªÖÎÁÆ·½·¨Ö®Ò»±»¹ã·ºÔËÓᣱ¾ÎľͰüÀ¨¹â»¯Ñ§ÁÆ·¨£¬Õ­Æ×Öв¨×ÏÍâÏߣ¬308ª²nm×¼·Ö×ӵȹâÁÆ·¨½üÄêÀ´µÄ·¢Õ¹×÷Ò»×ÛÊö¡£
¡¡¡¡¡¾¹Ø¼ü´Ê¡¿ °×ñ°·ç ¹â»¯Ñ§ÁÆ·¨ Õ­Æ×Öв¨×ÏÍâÏß 308 nm×¼·Ö×Ó
¡¡¡¡ÖÚËùÖÜÖª£¬°×ñ°·çÎªÒ»É«ËØÍÑʧÐÔ¼²²¡£¬ÑÏÖØÓ°Ïì×Å»¼ÕßÉíÐĽ¡¿µ£¬ÌرðÊDZ©Â¶²¿Î»µÄ»¼ÕßÒ»°ã¾ßÓгÁÖØµÄ¾«Éñ¸ºµ£¡£µ«Æù½ñΪֹ£¬ÒòÆä¾ßÌ岡ÒòÉв»ÍêÈ«Çå³þ£¬ÓÐÒ×Õï¶ÏÄÑÖÎÁƵÄÌØµã£¬Òò´Ë£¬Ä¿Ç°¶à²ÉÓÃ×ÛºÏÁÆ·¨£¨°üÀ¨ÊÖÊõ£¬Ò©Îï¼°ÎïÀíÖÎÁÆ£©¡£¶ø¹â»¯Ñ§ÁÆ·¨×÷ΪÎïÀíÖÎÁƵÄÖØÒª²¿·Ö£¬Îª´ó¼ÒËù¹Ø×¢£¬±¾ÎľͽüÄêÀ´°×ñ°·çµÄ¹âÁÆÑо¿½øÕ¹×÷Ò»×ÛÊö¡£
 

 
¡¡¡¡1 ¹â»¯Ñ§ÁÆ·¨
¡¡¡¡¹â»¯Ñ§ÁÆ·¨Êǽ«¹âÃô¼ÁºÍ³¤²¨×ÏÍâÏߣ¨320ª²480nmµÄ×ÏÍâÏߣ¬Ð¡²¿·Ö±»±íƤÎüÊÕ£¬´ó²¿·ÖÄÜ͸¹ý±íƤ´ïÕæÆ¤£¬ÉõÖÁÕæÆ¤Öв¿£©½áºÏÖÎÁƼ²²¡µÄ·½·¨¡£Æä¿ÉÄÜ»úÖÆ£º´Ù½øºÚËØÏ¸°ûDNA¸´ÖÆ£¬Ê¹Ï¸°ûÓÐË¿·ÖÁÑÖÜÆÚËõ¶Ì£¬ºÚËØÐ¡ÌåÊýÄ¿£¬ºÚËØÏ¸°ûÍ»Ôö¶à£¬ÀÒ°±Ëá±í´ïÔö¼Ó¼°Óй¦ÄܵĺÚËØÏ¸°ûÊýÁ¿Ôö¼Ó£¬Ä¿Ç°Ö÷ÒªÓÐÒÔϼ¸ÖÖ¡£
¡¡¡¡1.1 ²¹¹ÇÖ¬ËØ¹â»¯Ñ§ÁÆ·¨£¨PUVA£© ¼×Ñõ²¹¹ÇÖ¬ËØ1948Äê¼´ÓÃÓÚÖÎÁư×ñ°·ç£¬µ«×ÏÍâÏß¼Ó²¹¹ÇÖ¬ÖÎÁư×ñ°·çÊÇÓÚ1974ÓÉParrishÊ×ÏÈÌá³ö£¬×î³õÊÇÓÃÓÚÖÎÁÆÒøÐ¼²¡£¬²»¾Ã¼´·¢ÏÖUVA¿ÉÒÔ¼¤»î¼×Ñõ²¹¹ÇÖ¬ËØµÄ»îÐÔ£¬Ò»Ö±ÑØÓÃÓÚ½ñ¡£ÏÖ¶à²ÉÓõķ½·¨ÊÇ£Û1£Ý£º¶ÔÓÚ·º·¢ÐÔ°×ñ°·ç»ò¾Ö²¿ÖÎÁÆÎÞЧÕߣ¬ÖÎÁÆÇ°Ê×Ïȿڷþ¼×Ñõ²¹¹ÇÖ¬ËØ£¨0.5¡«0.6mg/kg£©Á½Ð¡Ê± ºóÕÕUVA¡£ÖÎÁÆÇ°Ó¦Ê×ÏȲⶨ×îС¹â¶¾Á¿£¨MPD£©£¬Ê×´ÎÖÎÁÆÁ¿Ò»°ã1/2¡«3/4MPD£¬ÒÔºó¸ù¾ÝÇé¿öÿ¸ô1¡«2´ÎÔö¼Ó1/4¡«1/2MPD¡£¶ÔÓÚÖйúÈËÆ¤·ô£¬UVAµÄ×î³õ¼ÁÁ¿Í¨³£ÊÇ1¡«2J/cm2£¬Ã¿´ÎÔö¼Ó0.25¡«0.5J/cm2£¬Ö±µ½ºì°ß³öÏÖ£¬Ã¿ÖÜ2¡«3´Î£¬Ò»¸öÁƳ̿ɳ¤´ï30´Î»ò¸ü¶à¡£ÖÎÁÆÖÐ´ó²¿·ÖÆ¤ËðÏûÍË»òÃ÷ÏÔºÃתʱ¸ÄÓÃά³ÖÁ¿£¬¼´1¡«2ÖÜÕÕÉä1´Î¡£¶ø¶ÔÓÚÆ¤Ëð·¶Î§Ð¡£¬ÊýÄ¿ÉÙÕߣ¬¿ÉÓÚÆ¤Ëð´¦Í¿0.2%µÄ¼×Ñõ²¹¹ÇÖ¬ôú£¬0.5Сʱºó¹âÕÕ¡£ÉÏÊöÖÎÁÆÊ±¾ùÓ¦´÷»¤Ä¿¾µ±£»¤Õý³£Æ¤·ô£¬ÒÔ¾¡¿ÉÄܵļõÉٹⶾ·´Ó¦¡£½üÀ´ÓÐÈËÌá³öÓü×Ñõ²¹¹ÇÖ¬ËØ´úÌæ¼×Ñõ²¹¹ÇÖ¬ËØ£¬¹â¶¾¸±×÷ÓøüС¡£ µ« PUVAÓÐ×Ų»ÊÊÓÚ12ËêÒÔϵĶùͯӦÓ㬾ßÓйⶾÐÔ£¬Ò×ÖÂÆ¤·ôÀÏ»¯£¬°×ÄÚÕϼ°ÓÕ·¢Æ¤·ôÖ×ÁöµÈÌØµã¡£
¡¡¡¡1.2 ¿­ßø¹â»¯Ñ§ÁÆ·¨£¨KUVA£© ¿­ßøÊÇÒ»ÖÖ߻૲¢É«Í­£¬Æä»¯Ñ§½á¹¹¼°ÉúÎï»îÐÔ¾ùÀàͬÓÚ²¹¹ÇÖ¬£¬µ«¶¾ÐÔÏà¶Ô½ÏС£¬°²È«ÐԺöø»¼ÕßÒÀ´ÓÐԸߣÛ2£Ý¡£Hofer A µÈѡȡÁË28Àý·º·¢ÐÔ°×ñ°·ç»¼Õߣ¨ÄÐ13Ãû£¬Å®15Ãû£»Æ½¾ù15¡«51Ë꣬ƽ¾ù34Ë꣩£¬¾ùÔÚ14ÄêµÄij¶Îʱ¼ä½ÓÊÜÁ˳¬¹ý6¸öÔµÄKUVAµÄÖÎÁÆ£¬Í¨¹ýÖÎÁÆÇ°ºóͼƬ¶Ô±ÈÖÎÁÆÇ°ºóƤËðÇøÉ«ËØ»Ö¸´Çé¿ö½øÐÐÏà¹Ø·ÖÎö·¢ÏÖÊǾßÓÐͳ¼ÆÑ§ÒâÒåµÄ£¬ÁÆÐ§Í¬ÖÎÁÆ´ÎÊý£¨r=0.833£¬£Ð=0.001£©£¬Í¬UVAµÄÀÛ»ý¼ÁÁ¿£¨r=0£¬840£¬£Ð=0.001£©¶¼ÓÐÏà¹ØÐÔ¡£ÔÚ³ÖÐøÖÎÁÆÊ±¼ä³¬¹ý3¸öÔµIJ¡ÈËÖУ¬Æ½¾ùÖÎÁÆ´ÎÊý´Î194£¨69¡«386£©£¬Æ½¾ùµÄUVAÀÛ»ý¼ÁÁ¿2.036J/cm2£¨690¡«4411J/cm2£©£¬ 41%µÄ»¼ÕßЧ¹û½ÏºÃ£¨ÈçÆ¤Ëð´¦70%µÄÉ«ËØµÃµ½Á˻ָ´¡£×î³£¼ûµÄ¶ÌÆÚ¸±×÷ÓÃÊÇÇá΢µÄ¶ñÐÄ£¬28¸ö»¼Õß¹²ÓÐ8¸ö³öÏÖ£¬¶øÇÒÖ÷ÒªÔÚÖÎÁƵÄ×î³õ¼¸¸öÖܳöÏÖ£»ÔÚKUVAÖÎÁƽáÊøºó³¤´ï4¡«110¸öÔ£¨Æ½¾ù40¸öÔ£©µÄËæ·ÃÆÚÄÚ£¬28ÈËÖÐÄÜËæ·Ãµ½µÄ23È˾ùûÓгöÏÖÆ¤·ô°©ºÍ¹â»¯ÐÔÆ¤·ô²¡£¬½á¹û³ä·ÖÖ¤Ã÷KUVAÖÎÁư×ñ°·ç£¬¼ÙÈçÖÎÁÆÊ±¼ä×ã¹»£¬²»½öÊÇÓÐЧµÄÒ²Êǰ²È«µÄ¡£Clrlie G µÈÈË£Û3£Ýͨ¹ýÌåÍâʵÑé²ûÃ÷KUVAµÄÖÎÁÆ»úÖÆ£º±»UVA¼¤»îµÄ¿­ßø´Ì¼¤Á˺ÚËØÏ¸°ûµÄÔöÖ³ºÍºÚÉ«ËØµÄÉú³É¡£Valkovas £Û4£Ý¹Û²ìµ½É«Ëػָ´Í¬ÄêÁäÓн̴óµÄÏà¹ØÐÔ£¨É«Ëػָ´ÂÊ=81.76£¨1.48*»¼ÕßÄêÁ䣩¡£
¡¡¡¡1.3 ±½±û°±Ëá¹â»¯Ñ§ÁÆ·¨ ±½±û°±ËáÁªºÏUVAÖÎÁư×ñ°·ç1983Äê¼´ÓÃÓÚÁÙ´²£¬ÏÖ¶à²ÉÓñ½±û°±ËáµÄǰÌå×óÐý±½±û°±ËᣬËüÄÜÔÚÀÒ°±ËáøµÄ×÷ÓÃϺϳɺÚÉ«ËØ¡£´Ë·¨ÓÅÓÚÆäËüÁÆ·¨ÔÚÓÚËüÄÜÌá¸ß°×°ßÇøÆ¤·ô¶Ô¹âµÄÄÍÊÜÐÔ¡£KniterµÈÔø¶Ô21Àý»¼ÕßÓ¦ÓÃ×óÐý±½±û°±Ëá¼ÓUVAÖÎÁư×ñ°·ç£¬×ÜÓÐЧÂÊ´ïµ½ÁË85%´ËÁÆ·¨¸üÄÜÌá¸ß°×°ßÇøÆ¤·ô¶Ô¹âµÄÄÍÊÜÐÔ£¬ÔÚ¹úÍâÒÑÍÆ¹ãÓ¦Óá£
¡¡¡¡1.4 ¿¨²´Èý´¼¹â»¯Ñ§ÁÆ·¨£Û5£Ý ºÚËØÏ¸°û±íÃæ±í´ïάÉúËØD3ÊÜÌ壬1£¬25¶þôÇάÉúËØD3¿Éµ÷½ÚºÚËØºÏ³É£¬¿¨²´Èý´¼ÏµÎ¬ÉúËØD3 1£¬25£¨OH£©2D3»îÐÔ´úлÎïµÄÀàËÆÎËü¿ÉÄÜͨ¹ýºÚÉ«ËØÏ¸°ûÉϵÄάÉúËØD3ÊÜÌå»òµ÷½Úϸ°ûÄÚ¸ÆÎÉÂÒ¶ø·¢»Ó×÷ÓãÛ6£Ý¡£2001ÄêErimsµÈÈËѡȡ35ÀýѰ³£ÐͰ×ñ°·ç»¼Õߣ¬²ÉÓÃËæ»ú˫ä¶ÔÕÕʵÑ飬Ñо¿½á¹ûÏÔʾ¿¨²´Èý´¼¹â»¯Ñ§ÁÆÐ§¹ûÁ¼ºÃ¡£
¡¡¡¡2 Õ­Æ×Öв¨×ÏÍâÏߣ¨NBUVB£©
¡¡¡¡1997ÄêWesterhof£Û7£ÝÂÊÏÈÓÃÓÚ°×ñ°·çµÄÖÎÁÆ£¬2001ÄêScherschem L£Û8£Ý ÔÙ´Îͨ¹ýÊÔÑé¿Ï¶¨ÆäÁÆÐ§¡£2007ÄêYonessµÈ£Û9£ÝѡȡÁË65Ãû·Ç½Ú¶ÎÐÔ°×ñ°·çµÄ»¼Õߣ¬²ÉÓÃË«Ã¤Ëæ»ú¶ÔÕÕÊÔÑ飬ÖÎÁÆ12¸öÔºó¹Û²ìÆäÁÆÐ§£¬½á¹û·¢ÏÖÔڷǽڶÎÐÔ°×ñ°·ç»¼ÕßÖУ¬NBª²UVBÓÅÓÚÆÕͨµÄPUVA¡£Ä¿Ç°ÆÕ±éÈÏΪNBª²UVBÊÊÓÚ·º·¢ÐÔ°×ñ°·çµÄÈ«ÉíÖÎÁÆ£¬ÁÆÐ§ÓëÀÛ»ýÕÕÉä´ÎÊýÃÜÇÐÏà¹Ø£¬ÕÕÉä´ÎÊýÒÔÿÖÜ1~2´ÎΪÒË£¬Ò»°ã1Ôºó²ÅÄÜÏÔЧ£¬ÁƳÌÐè°ëÄêÒÔÉÏ¡£NijooµÈ£Û10£Ý»¹Ó¦ÓÃ311nm NBª²UVBÖÎÁÆ51Àý·º·¢ÐÔ°×ñ°·ç»¼¶ù£¬¹Û²ì½á¹ûÈÏΪNBUVB ÖÎÁƶùͯ°×ñ°·çÒ²ÊÇÓÐЧµÄºÍ°²È«µÄ£¬¿ÉÒÔÃ÷ÏÔÌá¸ßÉú»îÖÊÁ¿¡£
 

 
¡¡¡¡3 308nm×¼·Ö×Ó
¡¡¡¡308ª²nm×¼·Ö×Ó¼´ÂÈ»¯ë¯×¼·Ö×Ó£¬ÊÇÒ»ÖÖÐÂÐ͵ÄÒ½Óü¤¹â£¬Æä²¨³¤ÔÚUVB·¶Î§ÄÚ¡£308ª²nm×¼·Ö×Ó×îÉî¿ÉÖÁ1.5nmµÄÕæÆ¤Ç³²ã£¬ÇÒÖ»Õë¶ÔƤËð²¿Î»£¬Òò´Ë¶ø¾ßÓиßÑ¡ÔñÐÔ¡££Û11£ÝNovakͨ¹ýÑо¿ÏÔʾÆä×÷ÓûúÖÆÖ÷ÒªÓëÆä¿É´Ùʹ°×ñ°·çƤËðÄڻµÄTϸ°ûµòÍöÓйء£2002ÄêÃÀ¹úSpencerÊ״ᨵÀÔËÓÃËüÖÎÁư×ñ°·çµÄ½á¹û£¬¹úÄÚ2005ÄêÑî»ÛÀ¼µÈ£Û12£Ý¹Û²ìÁ˽ü500Àý¸÷ÐͰ×ñ°·çµÄ»¼Õߣ¬Í¨³£308nm×¼·Ö×Ó5¡«6´Î£¬Ô­ÓеÄÍêÈ«ÐÔ°×°ßÉÏ¿ªÊ¼³öÏÖµã×´µÄÉ«ËØµº£¬¾­¹ýÿÖÜ2´Î¹²10ÖܵÄÖÎÁÆ£¬10%¡«15%µÄ»¼Õß¿ÉÍêÈ«¸´É«£¬ÏÔЧÂʿɴï50%×óÓÒ£¬ÓÐЧÂÊÔò´ï90%ÒÔÉÏ£Û13£Ý¡£Passeron T µÈÈËҲͨ¹ýÑо¿Ö¤Êµ£º308nm×¼·Ö×ÓÖÎÁƾÖÏÞÐÔ°×ñ°·çµÄÓÐЧÐԺͰ²È«ÐÔ¶¼Êǿ϶¨µÄ£¬µ«ÊÇÔËÓÃÓÚ×ÏÍâÏßÃô¸ÐÇøÓò£¨ÈçÃæ£¬¾±£¬Çû¸ÉµÈ²¿Î»£©Ð§¹û¸üΪÏÔÖø¡£¾ÝÏÖÓеÄÎÄÏ×£¬ÎÒÃÇÈÏΪ308nm×¼·Ö×ÓµÄÖ÷ÒªÊÊÓ¦Ö¢»¹ÊǾ²Ö¹ÆÚ°×ñ°·ç»¼Õߣ¬ÓÈÆäÊÇÃæ»ý½ÏСµÄ»¼Õß¡£ÆäÖ÷Òª¸±×÷ÓÃÊÇÖÎÁƲ¿Î»µÄºì°ß£¬Í¬Ê±Ò²¿ÉÒÔ³öÏÖË®ð壬´ÌÍ´²»ÊÊ£¬ÒÔ¼°µ¼ÖÂÆ¤·ôÖ×ÁöµÈ£Û14£Ý£¬µ«Æäµ¼ÖÂÖ×ÁöµÄΣÏÕÐÔËæ×ÅÀÛ»ýÕÕÉä¼ÁÁ¿µÄÔö¼Ó¶øÔö¼Ó£¬¶ø308nm×¼·Ö×ÓÖÎÁư×ñ°·çµÄÀÛ»ýÕÕÉäÁ¿Ô¶µÍÓÚNBUVB¡£Òò´Ë£¬ÔÚÁÙ´²É϶à´Î±»Ö¤Ã÷¾ßÓбÈPUVAºÍNBUVB¸üºÃµÄÁÆÐ§£¬É«ËØ¿ìËÙÔÙÉúÇÒά³Öʱ¼ä³¤¾Ã¡£
¡¡¡¡4 ÁªºÏÖÎÁÆ
¡¡¡¡Passeron T£Û13£ÝµÈÈËѡȡ14Ãû»¼ÕßÓÃ0.1%Ëû¿ËĪ˾Èí¸àÁªºÏ308nm×¼·Ö×Ó£¬½á¹ûÏÔʾ¶þÕßÁªºÏÁÆÐ§ÓÅÓÚÁ½Õ߸÷×Ôµ¥¶ÀʹÓÃ308nm×¼·Ö×Óͬ¿¨²´Èý´¼ÁªºÏÖÎÁÆÒ²ÓнϺõÄÁÆÐ§……Ostovari N£Û15£ÝµÈÈ˱¨µÀËû¿ËĪ˾ÔÚûÓÐUVBµÄÇé¿öÏÂÖÎÁư×ñ°·çÊÇȱ·¦ÓÐЧÐԵġ£Mehrabi D£Û16£Ý ͨ¹ýËæ»ú£¬Ë«Ã¤£¬°²Î¿¼Á¶ÔÕձȽÏÑо¿·¢ÏÖÔÚ·º·¢ÐÔ°×ñ°·çµÄÖÎÁÆÖУ¬Ëû¿ËĪ˾ÁªºÏNBUVBÊÇÓÅÓÚµ¥¶ÀʹÓÃNBUVBµÄ£¬½øÒ»²½ËµÃ÷ÁËÁ½Õß¾ßÓÐЭͬ×÷ÓãÛ16£Ý¡£NBUVBͬ¿¨²´Èý´¼£¬¼¤ËØÀàÈí¸àÈç£Û17£Ý·ú¿¨ÌæËáͬUVA½áºÏʹÓõÄЭͬЧӦ£¬Òà¶¼Óб¨µÀ¡£²»½öÈç´Ë£¬¶ÔÓÚÐÐ±íÆ¤Ï¸°ûÒÆÖ²µÄ°×ñ°·ç»¼Õߣ¬UVAÄÜÔö¼ÓÆäÖÎÓúÂÊ£Û18£Ý¡£ÓÐÑо¿ÏÔʾ°×ñ°·ç»¼ÕßѪҺÖÐÒ¶ËáºÍ΢ÉúËØB12ˮƽµÍÓÚ³£ÈË¡£Julin£Û19£ÝµÈѡȡ100Àý°×ñ°·ç»¼Õߣ¬¸øÒÔ¿Ú·þÒ¶ËáºÍάÉúËØB12£¬ÏÄÌìÕÕÉäÈչ⣬¶¬ÌìÕÕÉäUVB£¬ÖÎÁÆÊ±¼äÖÁÉÙ´óÓÚ3¡«6Ô£¬½á¹û±íÃ÷52ÀýÓÐÃ÷ÏÔЧ¹û£¬±©¹â²¿Î»É«Ëػָ´Ã÷ÏÔ£¬38%»¼Õ߻ָ´×îÃ÷ÏÔµÄʱ¼äÊÇÏᄀ£µ«Ðè½øÒ»²½Ñо¿Ã÷ȷάÉúËØ¼°¹âÕÕµÄ×îС¼ÁÁ¿¼°ÁƳ̡£
¡¡¡¡¶ø¹úÄÚ¸ü¶àµÄ±¨µÀÊÇNBUVBÓëÌÇÆ¤Öʼ¤ËØÈí¸à£¨ÈçËû¿¨Î÷´¼£¬Â±ÃÀËÉ£©£»ÓëÃâÒßÒÖÖÆ¼Á£¨ÈçËû¿ËĪ˾£©£¬¹âÁÆÍ¬ÖÐÒ©ÖÆ¼Á£¨È縴·½¿¨Á¦×ÎÈ»ôú£©£¬ÒÔ¼°ÖвÝÒ©£¬Õë¾ÄµÈ׿¹úҽѧÁªºÏÖÎÁƾùÈ¡µÃÁËÒ»¶¨µÄÁÆÐ§¡£
¡¡¡¡Ëæ×ÅҽѧÊÂÒµÈÕÐÂÔÂÒìµÄ·¢Õ¹£¬ÒÔ¼°¶ÔÓÚ°×ñ°·çÑо¿µÄ½øÒ»²½ÉîÈ룬ÎÒÃÇÏàÐŹâÁÆÒ»¶¨ÄܸüºÃµÄÓÃÓÚ°×ñ°·çµÄÖÎÁÆ¡£
¡¡¡¡¡¾²Î¿¼ÎÄÏס¿
¡¡¡¡£Û1£Ý Mc Nedy W£¬Goa KL. 5ª²Methoxypsoralen A review of its effects in psoriasis and vitiligo£ÛJ£Ý¡£ Drugs£¬1998£¬56£¨4£©£º667¡«690.
¡¡¡¡£Û2£Ý Hofer A£¬Kerl H£¬Holf P. Longª²term results in the treatment of vitiligo with oral khellin plus UVA£ÛJ£Ý¡£ Eur J Dematol.2001 Mayª²June;11£¨3£©£º225¡«229.
¡¡¡¡£Û3£Ý Carlie G£¬ Ntusi NB£¬Hulley PA£¬Kidson SH. KUVA stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro£ÛJ£Ý¡£ Br J Dermatol.2003 oct£¬149£¨4£©£º707¡«717.
¡¡¡¡£Û4£Ý Valkova S£¬Trashlieva M£¬ Christova P. Treament of vitiligo with local khellin and UVA£¬comparison with systemic PUVA£ÛJ£Ý¡£Clin Exp Dematol.2004 May£¬29£¨2£©£º180¡«184.
¡¡¡¡£Û5£Ý Schallreuter KU£¬Moore J£¬Behrensª²Williams s. Rapid initiation of repigmentation in vitiligo with Dead sea climatotherapy in combination with pseudocatalase £¨pcª²ku£©£ÛJ£Ý¡£In J Dtrmatol 2002£¬41£¨8£©£º482¡«487.
¡¡¡¡£Û6£Ý Ermis O£¬ A lpsoy E£¬Cetin L£¬et al.Is the efficacy of psoralen plus ultraviolet A the rapy for vitiligo enhanced by concurrent topical calcipotriol£ÛJ£Ý£¬Br J Dermatol£¬2001£¬11£¨3£©£º225¡«229.
¡¡¡¡£Û7£Ý Westerhof W£¬Nieuweboerª²Kroboreova L. Teatment of vitiligo with UVª²B radiation vs topical psoralen plus UVA£ÛJ£Ý¡£ Arch Dermatol£¬1997£¬33:1525¡«1528.
¡¡¡¡£Û8£Ý Scherschun L£¬Kim JJ£¬ Lim HW. Narrow band ultrabiolet B is a userul and well tolerated treatment for bitiligo£ÛJ£Ý¡£J Am Acad Dermatol£¬2001£¬44:999¡«1003.
¡¡¡¡£Û9£Ý Yoness ss. Palmer RA. Garibaldinos TM.HAWKJL Randomized doubleª²blind trial of treatment of vitiligo :efficacy of psoralenª²uvª²A therapy vs Narrowbandª²uvª²B therapy£ÛJ£Ý¡£ Arch.Dermatol£¬2007 May£¬Jul£¬143£¨7£©£º906.
¡¡¡¡£Û10£ÝNjoo MD£¬Bos JD£¬Westerhof W. Trenment of generalized vitiligo in children with narrowª²band radiation therapy£ÛJ£Ý¡£ J Am Acad Dermatol£¬2000£¬42£¨2 pt 1£©£º245¡«253.
¡¡¡¡£Û11£ÝNovak Z£¬Bonis B£¬Baltas E£¬et al.Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrowª²band ultraviolet B£ÛJ£Ý¡£ Photochem Photohiol B£¬2002£¬67£¨1£©£º32¡«38.
¡¡¡¡£Û12£ÝÑî»ÛÀ¼£¬ÁõÖÙÈÙ£¬ÎâÑàºìµÈ¡£°×ñ°·çµÄ¹âÁÆ·¨£ÛJ£Ý¡£ÖйúÃÀÈÝҽѧ£¬ 2006£¬8£¬15£¨8£©£º977.
¡¡¡¡£Û13£ÝPasseron T£¬Ostovari n£¬Zakaria W£¬Fontas E£¬et al. Topical tacrolimus and the 308ª²nm excimer laser:a synergistic combination for the treatment of vitiligo.
¡¡¡¡£Û14£ÝÀîãüܰ£¬¸ßÌìÎÄ¡£308nm×¼·Ö×ÓÖÎÁư×ñ°·ç½øÕ¹£ÛJ£Ý¡£ÖйúƤ·ôÐÔ²¡Ñ§ÔÓÖ¾£¬2006£¬8£¬20£¨8£©¡£
¡¡¡¡£Û15£ÝOstovari N£¬Passeron T£¬Lacour JP£¬Ortonne JP. Lack of efficacy of tacrolimus in the treatment of vitiligo in the abensce of UVª²B exposure£ÛJ£Ý¡£ Arch Dermatol£¬2006 Feb£¬142£¨2£©£º252¡«253.
¡¡¡¡£Û16£ÝMehrabi D Pandya AG.A randomized£¬placeboª²controlled£¬doubleª²blind trial comparing narrowband UVª²B plus 0.1% tacrolimus ointment with narrowband UVª²B plus placebo in the treatment of generalized vitiligo.
¡¡¡¡£Û17£ÝDogra S.Parsad D. Combination of narrowband UVª²B and topical calcipotriene in vitiligo£ÛJ£Ý¡£ Arch Dermatol.2003 Mar£¬139£¨3£©£º393.
¡¡¡¡£Û18£ÝAwad ss. Abdelª²Raof H. Hosam EIª²Din W.EIª²Domyatim. Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate£ÛJ£Ý¡£ J Cosmet Dermatol.2007 Jun£¬6£¨2£©£º119¡«124.
¡¡¡¡£Û19£ÝJuhlin L,Olsson MJ. Improvement of vitiligo after oral treatment with vitaminB12 and folic acid and the importance of sun exposure£ÛJ£Ý¡£Acta Dermvenerol.1997 NOV£¬77£¨6£©£º460¡«462.

ÔÚÏß×Éѯ ÔÚÏß×Éѯ

ÎÂܰÌáʾ£ºÈçÓÐÒÉÎÊ£¬¿ÉÃâ·Ñ×ÉѯÔÚÏßÒ½Éú£¬»ò²¦´ò²¦´ò±¾Ôº24СʱÈÈÏߣº400-040-9907£¬ÎÒÃÇ»á´ÓרҵµÄ½Ç¶ÈÈÏÕæ½â´ðÄãµÄÒÉÎÊ¡£´ËÍ⣬ÄúÒ²¿Éµ½ÎÒÃÇһ¥´óÌü×ÉѯÏà¹ØÎÊÌ⣬ÎÒÃǵķþÎñÈËÔ±½«ÈÈÇéµÄΪÄú·þÎñ£¡ÉùÃ÷£º±¾Õ¾²¿·ÖÐÅÏ¢À´×ÔÍøÂ磬½ö¹©²Î¿¼£¬²»ÄÜ×÷ΪÕï¶Ï¼°Ò½ÁƵÄÒÀ¾Ý¡£ÈçÄã×ªÔØ»òÒýÓñ¾ÎÄ£¬Çë±êעת×Ô£ºhttps://www.immergy.com

°×ñ°·çȨÍþר¼Ò

²é¿´ÏêÇé

Â޼̻¢ ¿ÆÊÒÖ÷ÈÎ

Â޼̻¢ ¿ÆÊÒÖ÷ÈÎ

Â޼̻¢Ê×ϯר¼Ò¡¢²©Ê¿Éúµ¼Ê¦£¬°×ñ°·çÁìÓòµÄѧÊõÇ̳þ ÖлªÒ½Ñ§»áƤ·ô¿Æ³£ÎñÀíÊ¡¢Öйú°×ñ°·çЭ»á»áÔ±¡£±ÏÒµÓÚºÚÁú½­Ê¡ÆëÆë¹þ¶ûҽѧԺ£¬ÔøÏȺó...[Ïêϸ]

³ÂÉÆìÏ ¸±Ö÷ÈÎҽʦ

³ÂÉÆìÏ ¸±Ö÷ÈÎҽʦ

³ÂÉÆìϸ±Ö÷ÈÎҽʦÖлªÒ½Ñ§»áƤ·ô¿ÆÎ¯Ô±»áίԱ¡¢Öйú°×ñ°·çЭ»áר¼Ò×é³ÉÔ±£¬Æ¤·ô²¡Ñ§Öص㼼Êõ·¢Ã÷½±»ñµÃÕß¡£Ôøµ£ÈÎÎ÷ÄÏ´óѧר¼Ò...[Ïêϸ]

Ò½Ôº¼ò½é

Ò½Ôº¼ò½é
¸£ÖÝÖпư×ñ°·çÑо¿ËùÊǾ­Óйز¿ÃÅȫίÅú×¼£¬Ñϸñ°´ÕÕÊÀ½çÎÀÉú×éÖ¯...[Ïêϸ]

ÈÈÃŹؼü´Ê

ÔÚÏß×Éѯ